Eicosapentaenoic acid restores tamoxifen sensitivity in breast cancer cells with high Akt activity

Annals of Oncology

Volumn 14, Issue 7, 2003, Pages 1051-1056

  deGraffenried, L A ^a   Friedrichs, W E ^a   Fulcher, L ^a   Fernandes, G ^a   Silva, J M ^a   Peralba, J M ^b   Hidalgo, M ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Akt; n 3 fatty acids; Tamoxifen

Indexed keywords

ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; PROTEIN KINASE B; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; DRUG RESPONSE; DRUG SENSITIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0041853713     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdg291     Document Type: Article

References (20)

1. Lupu R, Cardillo M, Cho C et al. The significance of heregulin in breast cancer tumor progression and drug resistance. Breast Cancer Res Treat 1996; 38: 57-66.
2. Kato S, Endoh H, Masuhiro Y et al. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 1995; 270: 1491-1494.
3. Campbell RA, Bhat-Nakshatri P, Patel NM et al. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J Biol Chem 2001; 276: 9817-9824.
4. Zimmermann S, Moelling K. Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 1999; 286: 1741-1744.
5. Hii CS, Moghadammi N, Dunbar A, Ferrante A. Activation of the phosphatidylinositol 3-kinase-Akt/protein kinase B signaling pathway in arachidonic acid-stimulated human myeloid and endothelial cells: involvement of the ErbB receptor family. J Biol Chem 2001; 276: 27246-27255.
6. Mirnikjoo B, Brown SE, Kim HF et al. Protein kinase inhibition by omega-3 fatty acids. J Biol Chem 2001; 276: 10888-10896.
7. Kohn AD, Takeuchi F, Roth RA. Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation. J Biol Chem 1996; 271: 21920-21926.
8. Franke TF. Assays for Akt. Methods Enzymol 2000; 322: 400-410.
9. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 1992; 339: 1-15.
10. Nicholson KM, Anderson NG. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 2002; 14: 381-395.
11. Robertson JF. Oestrogen receptor: a stable phenotype in breast cancer. Br J Cancer 1996; 73: 5-12.
12. Triboulot C, Hichami A, Denys A, Khan NA. Dietary (n-3) polyunsaturated fatty acids exert antihypertensive effects by modulating calcium signaling in T cells of rats. J Nutr 2001; 131: 2364-2369.
13. Yu C, Chen Y, Zong H et al. Mechanism by which fatty acids inhibit insulin activation of IRS-1 associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 2002; 277: 50230-50236.
14. Park Y, Allen KG, Shultz TD. Modulation of MCF-7 breast cancer cell signal transduction by linoleic acid and conjugated linoleic acid in culture. Anticancer Res 2000; 20: 669-676.
15. Hardman WE, Avula CP, Fernandes G, Cameron IL. Three percent dietary fish oil concentrate increased efficacy of doxorubicin against MDA-MB 231 breast cancer xenografts. Clin Cancer Res 2001; 7: 2041-2049.
16. Clark AS, West K, Streicher S, Dennis PA. Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells. Mol Cancer Ther 2002; 1: 707-717.
17. Calviello G, Palozza P, Piccioni E et al. Dietary supplementation with eicosapentaenoic and docosahexaenoic acid inhibits growth of Morris hepatocarcinoma 3924A in rats: effects on proliferation and apoptosis. Int J Cancer 1998; 75: 699-705.
18. Kurokawa H, Lenferink AE, Simpson JF et al. Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells. Cancer Res 2000; 60: 5887-5894.
19. Sun M, Paciga JE, Feldman RI et al. Phosphatidylinositol-3-OH kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor α. (ERα) via interaction between ERα and PI3K. Cancer Res 2001; 61: 5985-5991.
20. Tanaka M, Koul D, Davies MA et al. MMAC1/PTEN inhibits cell growth and induces chemosensitivity to doxorubicin in human bladder cancer cells. Oncogene 2000; 19: 5406-5412.